• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植候选者中与ABO血型相关的等待名单差异:终末期肝病模型(MELD)采用的影响

ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.

作者信息

Barone Michele, Avolio Alfonso W, Di Leo Alfredo, Burra Patrizia, Francavilla Antonio

机构信息

Section of Gastroenterology, D.E.T.O., University of Bari, Piazza G. Cesare, Bari, Italy.

出版信息

Transplantation. 2008 Mar 27;85(6):844-9. doi: 10.1097/TP.0b013e318166cc38.

DOI:10.1097/TP.0b013e318166cc38
PMID:18360266
Abstract

BACKGROUND

Blood group O candidates remain on the waiting list for a liver transplant for a longer time than candidates of other blood groups. Herein, we analyzed potential factors affecting waiting times in the period that preceded the introduction of the model for end-stage liver disease (MELD) and in MELD era, remarking possible corrections introduced by the adoption of the MELD.

METHODS

Our analysis was entirely based on data obtained from the "Organ Procurement and Transplantation Network", referring to the periods before and after the adoption of the MELD.

RESULTS

In the MELD era, taking into consideration all candidates, the cumulative probability of remaining on the waiting list significantly diminished whereas that of undergoing transplantation significantly increased when compared with the pre-MELD era. However, group O candidates maintained the lowest cumulative probability of undergoing liver transplant, in all MELD classes, and the highest percentage of list removal for death/too sick. What caused the highest disadvantage for group O, in both eras, was the use of group O organs for ABO-compatible transplants, even in the absence of urgency. In candidates receiving ABO-compatible organs a significantly lower graft survival rate was observed compared with candidates receiving ABO-identical organs, even when the analysis was adjusted for the MELD score.

CONCLUSIONS

The introduction of the MELD significantly reduced the waiting time for all candidates as also the shift of group O organs. Limiting ABO-compatible organs exclusively to urgent cases would have a positive effect not only in terms of individual justice, but also terms of in general utility, considering the effect of ABO-matching on graft survival.

摘要

背景

O型血的肝脏移植候选者在等待名单上的时间比其他血型的候选者更长。在此,我们分析了在终末期肝病模型(MELD)引入之前及MELD时代影响等待时间的潜在因素,并指出采用MELD可能带来的修正。

方法

我们的分析完全基于从“器官获取与移植网络”获得的数据,涉及采用MELD之前和之后的时期。

结果

在MELD时代,考虑所有候选者,与MELD时代之前相比,留在等待名单上的累积概率显著降低,而接受移植的概率显著增加。然而,在所有MELD分级中,O型血候选者接受肝脏移植的累积概率最低,因死亡/病情过重而从名单上移除的比例最高。在两个时代,导致O型血候选者处于最不利地位的原因是,即使不紧急,O型血器官也用于ABO血型相容的移植。在接受ABO血型相容器官的候选者中,观察到的移植物存活率显著低于接受ABO血型相同器官的候选者,即使在根据MELD评分进行调整的分析中也是如此。

结论

MELD的引入显著缩短了所有候选者的等待时间以及O型血器官的转移。将ABO血型相容器官仅用于紧急情况不仅在个体公平方面,而且从总体效用角度考虑ABO血型匹配对移植物存活的影响,都将产生积极效果。

相似文献

1
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.肝移植候选者中与ABO血型相关的等待名单差异:终末期肝病模型(MELD)采用的影响
Transplantation. 2008 Mar 27;85(6):844-9. doi: 10.1097/TP.0b013e318166cc38.
2
Use of "O" blood group liver donors for nonidentical recipients: does this represent a double penalty for "O" blood group candidates?将“O”血型肝脏供体用于非相同血型受体:这对“O”血型供体候选人来说是否意味着双重不利?
Transplant Proc. 2006 May;38(4):1063-5. doi: 10.1016/j.transproceed.2006.03.007.
3
Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.终末期肝病模型评分引入前后肝移植等待名单上的生存率
Transplant Proc. 2010 Mar;42(2):407-11. doi: 10.1016/j.transproceed.2010.01.005.
4
Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.肝移植等待名单中终末期肝病模型(MELD)评分分析
Transplant Proc. 2007 Oct;39(8):2511-3. doi: 10.1016/j.transproceed.2007.07.023.
5
Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?用于评估等待肝移植患者的终末期肝病模型(MELD)评分系统:比Child-Turcotte-Pugh(CTP)系统更好吗?
Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072.
6
Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.在一个单一中心进行的198例肝移植手术中,终末期肝病模型(MELD)评分与尸体供体的器官分配情况。
Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016.
7
Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.终末期肝病模型(MELD)系统用于肝脏分配与共享:两个意大利中心的经验
Transplant Proc. 2008 Jul-Aug;40(6):1814-5. doi: 10.1016/j.transproceed.2008.05.053.
8
Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.终末期肝病模型(MELD)在以色列是否有效?对肝移植等待名单死亡率的批判性分析。
Isr Med Assoc J. 2006 Sep;8(9):605-9.
9
Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation.紧急肝移植:供受者ABO血型匹配对移植后结局的可能影响。
Transplantation. 2003 Feb 15;75(3):347-53. doi: 10.1097/01.TP.0000044359.72379.E5.
10
Overview of the MELD score and the UNOS adult liver allocation system.终末期肝病模型(MELD)评分及器官共享联合网络(UNOS)成人肝脏分配系统概述。
Transplant Proc. 2007 Dec;39(10):3169-74. doi: 10.1016/j.transproceed.2007.04.025.

引用本文的文献

1
Disparities in Heart Transplantation Allocation and Outcomes by Blood Type in Korea (2010-2022).韩国血型对心脏移植分配及结果的差异(2010 - 2022年)
Korean Circ J. 2025 Jun;55(6):481-493. doi: 10.4070/kcj.2024.0281. Epub 2025 Mar 28.
2
Critical Evaluation of Discarded Donor Livers in the Eurotransplant Region: Potential Implications for Machine Perfusion.废弃供肝的批判性评估:对机器灌注的潜在影响——欧洲器官移植区域研究
Ann Transplant. 2023 Mar 17;28:e938132. doi: 10.12659/AOT.938132.
3
ABO blood group relationships to kidney transplant recipient and graft outcomes.
ABO 血型与肾移植受者和移植物结局的关系。
PLoS One. 2020 Jul 23;15(7):e0236396. doi: 10.1371/journal.pone.0236396. eCollection 2020.
4
Transplantation for hepatocellular cancer: pushing to the limits?肝细胞癌的移植治疗:是否已达极限?
Transl Gastroenterol Hepatol. 2018 Sep 14;3:61. doi: 10.21037/tgh.2018.09.07. eCollection 2018.
5
Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.2002 - 2014年美国慢性丙型肝炎病毒感染的肝移植:器官共享联合网络/器官获取与移植网络登记处分析
PLoS One. 2017 Oct 31;12(10):e0186898. doi: 10.1371/journal.pone.0186898. eCollection 2017.
6
Organizational learning-by-doing in liver transplantation.肝脏移植中的组织边做边学
Int J Health Econ Manag. 2018 Mar;18(1):25-45. doi: 10.1007/s10754-017-9222-z. Epub 2017 Aug 30.
7
Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States.在美国,种族/民族与ABO血型不匹配的肝移植相关。
Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13011. Epub 2017 Jun 19.
8
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.肝移植等待名单患者的肝细胞癌桥接和降期治疗。
World J Gastroenterol. 2013 Nov 21;19(43):7515-30. doi: 10.3748/wjg.v19.i43.7515.